Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ATAI Life Sciences N.V. - Common Shares (NQ: ATAI )

1.805 +0.255 (+16.45%)
Streaming Delayed Price Updated: 1:53 PM EST, Feb 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ATAI Life Sciences N.V. - Common Shares

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
26 27 Next >
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.55% at $0.13 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 7.70% at $0.78 
Via Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72 
Via Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36 
Via Benzinga
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
Awakn Life Sciences Files Patent For Exclusive Rights To Use Ketamine For Treating Behavioral Addictions
Photo by Adrien Converse on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Psychedelic Stock Gainers And Losers From June 3, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35 
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75 
Via Benzinga
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its... 
Via Benzinga
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 31, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36 
Via Benzinga
Psychedelic Compounds-Based Stocks Continue To Decline
Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From May 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34 
Via Benzinga
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 24, 2022
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61 
Via Benzinga
Cybin, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68 
Via Benzinga
Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 20, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77 
Via Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29 
Via Benzinga
Cybin, Allied Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55 
Via Benzinga
Psychedelics Atai Life Sciences: Optimizing Drug Development By Avoiding Big Pharma's Past Missteps
In the early days of the psychedelics industry, financial reports mean very little. Unless a company wildly misses its operating spending budget and hemorrhages cash by more than expected, the report... 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32 
Via Benzinga
Aurora Sky Is No More, Stablecoins Melt Down and SAFE Banking Receives Another Boost
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales, lead financial writer Benjamin A. Smith and millennial entrepreneur Anthony Varrell talk macro market, crypto, the dangers of algorithmic... 
Via Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 16, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
EXCLUSIVE: Atai Life Sciences Posts Earnings for Q1 2022, Advancing Key Milestones In Psychedelic Drug Development
Atai Life Sciences (NASDAQ: ATAI), a biotech company leading the development of psychedelic compounds for mental health purposes, issued its financial report for the first quarter of the year, ending... 
Via Benzinga
Psychedelic Compounds-Based Stocks Index Imploding
Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high. 
Via Talk Markets
Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 12, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 11, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS: 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.